Rankings
▼
Calendar
CGEM FY 2018 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CGEM
Cullinan Therapeutics, Inc.
$841M
FY 2018 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
Gross Profit
-$43,000
Operating Income
-$15M
Net Income
-$14M
EPS (Diluted)
$-17.74
Cash Flow
Operating Cash Flow
-$14M
Free Cash Flow
-$14M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$35M
Total Liabilities
$55M
Stockholders' Equity
-$21M
Cash & Equivalents
$34M
← Q1 2019
All Quarters
